Patent Information

(54) Name
CRYSTALLINE FORMS OF N-[4-(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-5-YL)PYRIDINE-3-CARBOXAMIDE
(21) Filing number
PT208510
(21) EP Number
3969117 (open in ep register)
(51) Classification
N/A
Supplementary Protection
N/A
(22) Application date
19/05/2026
(24) Registration date
09/06/2026
Expiry date
15/05/2027  Renew
Status
Registered  
Protection period
7

Priority Details

N/A

Applicant Details

    (731) Name / Company Address State Town Post code Country
    Novartis AG Lichtstrasse 35 Basel 4056 Switzerland

Inventor Details

    (731) Name / Company Address State Town Post code Country
    DODD, Stephanie Kay c/o Novartis Institutes for Bio Medical Research, Inc.,250 Massachusetts Avenue, Cambridge, New Jersey 02139 United States
    GRANDEURY, Arnaud c/o Novartis Pharma AG Postfach 4002 Basel Switzerland
    ROUSAKI, Evgenia c/o Novartis Pharma AG Postfach 4002 Basel Switzerland
    SUFFERT, Emmanuel c/o Novartis Pharma AG Postfach 4002 Basel Switzerland

Representative Details

    (731) Name / Company Address State Town Post code Country
    Dr. Luigi A. Sansone SALOMONE SANSONE 84-85, Melita Street Valletta VLT 1120 Malta

Address of Service 

N/A

All Documents

N/A